Researchers from the University of Newcastle have received extra funding to continue their studies into the connection between women's reproductive health and cancer.
The research project conducted by the University in collaboration with the Hunter Medical Research Institute will receive $566 000 dollars over the next three years from the Ovarian Cancer Research Foundation to help better understand how changes in a female's reproductive hormones affect their risk of developing ovarian cancer.
The intention is to investigate how medications already on the market, such as the oral contraceptive pill, can be utilised over an extended period to reduce the risk of developing the life-threatening disease.
Associate Professor Pradeep Tanwar says the project team hopes to alter the way the pill is perceived.
"With the pill, our aim is to shift the focus from birth control to cancer prevention," says Professor Tanwar. "We are developing a strong scientific foundation that shows the benefits of using contraceptive pills to reduce the risk of ovarian cancer and other gynaecological cancers."
 |
| Photo belonging to the University of Newcastle |
